For those who can work at all — around 8 in 10, one study found — accommodations are often what makes it possible. The costs ...

Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease.

Here are the latest national COVID-19 trends, according to the U.S. Centers for Disease Control and Prevention (CDC) and major wastewater surveillance providers: This summer’s COVID-19 wave is still ...

Changing seasons affect many people with Long COVID, myalgic encephalomyelitis, and other chronic illnesses, but not all in the same way. Research has a long way to go before it can explain the ...

Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.Britta Shoot ...

Advocates, clinicians, and researchers must prioritize prevention and demonstrate the gravity of infection-associated chronic conditions like Long COVID by providing and wearing masks at public events ...

In late August, hundreds of researchers, clinicians, advocates, and others gathered in Amsterdam for the inaugural conference organized by the recently created International Society for Long COVID and ...

While there are no data sources on Long COVID in prison, experts suspect rates of the disease may be higher there than in the general population. They face high reinfection risks and poor access to ...

The trial, run by researchers at McMaster University in Canada, is testing the Lightning Process, a pseudoscientific mind-body program that outside experts have heavily criticized. Source: Bruce ...

This commentary article was originally published in The Gauntlet, a Substack publication by Julia Doubleday. The Sick Times has republished it with permission. Last week, The Telegraph published an ...